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Background: In Japan, a traditional herbal medicine, Tokishigyakukagoshuyushokyoto (TJ-38), is often used for the
treatment of peripheral coldness, which is a common complaint among Japanese women. However, the effects of
this herbal medicine have yet to be examined in a randomized controlled trial. In the current study, the effect of
TJ-38 on the peripheral blood flow in women experiencing peripheral coldness was investigated using a
parallel-group randomized controlled trial.
Methods: Fifty-eight women aged 23 to 79 years with peripheral coldness were randomly divided into the
intervention or control group. They were examined using cold bathing tests, physical examinations, and questionnaires
in January 2010 for the baseline and in March 2010 for the follow-up, and January 2011 and March 2011, respectively.
Results: At the baseline, there were no differences in clinical characteristics between the two groups. In the
intervention group, peripheral coldness improved after the intervention term; however, it persisted in the
control group. Mean values of percentage recovery of the peripheral blood flow after cold bathing tests were
17.2% and −28.2% for the intervention and control groups, respectively (p = 0.007), and the proportions for
percentage recovery of >50% were 32% and 0%, respectively (p = 0.0007). Mean values of percent recovery of
skin temperature did not differ between the two groups.
Conclusions: The present clinical trial supports that a traditional herbal medicine relieves peripheral coldness in
women probably through the improvement of peripheral blood flow.Background
Peripheral coldness is a common symptom in Japanese
women, often complicating other symptoms such as
headaches, depressive moods, and fatigue [1-3]. Whilst it
is not a fatal disease, it can lead to a decreased quality of
life [4]. In previous studies [2,5], peripheral coldness was
observed in 39% of female university officials and 52% of
women who visited a gynecological clinic for regular
checkups, some of whom had gynecological or meno-
pausal complaints. The etiology of peripheral coldness is
not well established, but it could be associated with de-
creased peripheral blood flow. Women with peripheral
coldness in both the upper and lower extremities had* Correspondence: iso@pbhel.med.osaka-u.ac.jp
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unless otherwise stated.about 50% lower blood flow (as measured by a laser
Doppler meter) in the upper extremities and about 60%
lower blood flow in the lower extremities as compared
to those without peripheral coldness [6]. Another study
of 41 women with and without peripheral coldness
showed lower skin temperatures of the palms and feet,
as well as a larger temperature range in women with
peripheral coldness, as compared to those without per-
ipheral coldness [7]. Furthermore, women with periph-
eral coldness tend to have a lower body mass index and
less body fat than those without it [8]. In Japan, more
than 20% of women aged 20-29 years are underweight
(BMI 18.5 kg/m2) [9], and that percentage was much
higher than that in most developed countries, highlight-
ing the importance of effective treatment for peripheral
coldness.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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vitamin E and lifestyle modification. However, the effect-
iveness of these treatments has been questioned [10-12].
The administration of traditional herbal medicine is one
of the alternative approaches in the treatment of periph-
eral coldness, and has been reported to reduce symptoms.
Tokishigyakukagoshuyushokyoto (TJ-38) is a traditional
herbal medicine originally from Chinese medicine and
now used widely in Japan. TJ-38 is one of commonly used
traditional herbal medicine in Japan because it contains
vasodilators and anticoagulant ingredients such as evo-
diame, adenosine, ligustilide and butylidenephthalide
[13,14]. Previous case-analysis studies reported that TJ-38
improved patient’s symptoms associated with peripheral
coldness. A study with 181 patients with peripheral cold-
ness showed that the administration of TJ-38 improved
74% of participants’ peripheral coldness [15]. Also, another
case-report study showed that patient’s peripheral cold-
ness decreased 4 days after the start of TJ-38 administra-
tion [16]. However, no randomized controlled clinical trial
has been conducted to prove the effectiveness of TJ-38 in
adult women. Furthermore, the mechanism of reducing
peripheral coldness is unknown. Therefore, the purpose of
this study was to investigate, through a parallel group de-
signed randomized controlled trial, the effect of a trad-
itional herbal medicine on peripheral blood flow, skin




Written informed consent was obtained from all par-
ticipants. The study had been approved by the Ethics
Committee of the Osaka University Graduate School of
Medicine on December 17th, 2009 (No. 09152). The
authors confirm that all ongoing and related trials for
this drug/intervention are registered.
Inclusion and exclusion criteria
We included women aged 20 to 80 years who had expe-
rienced peripheral coldness for at least three years. The
exclusion criteria were pregnancy or any peripheral cir-
culatory disorders such as advanced diabetes mellitus,
Buerger’s disease, hypothyroidism, hyperthyroidism, and
connective tissue disorders.
Participants
Participants of this study were recruited via websites,
bulletin board postings, flyers, and newspaper advertise-
ments from October 22 to December 10 in 2009, and
November 5 to December 20 in 2010. Women interested
in the study attended explanatory seminars at Osaka
University Hospital and Osaka Medical Center for
Health Science and Promotion (currently Osaka Centerfor Cancer and Cardiovascular Disease Prevention). In
total, 75 women contacted the study office, and 58
women aged 23 to 79 years met the inclusion criteria
and agreed to participate in the study with written in-
formed consent.
Trial design
The design of the trial in this study was a parallel-group
randomized controlled trial. Participants were randomly
divided into intervention and control groups, and strati-
fied by age (<50 and ≥50). The allocation of the inter-
vention and control groups was performed using
random numbers. Concealed random numbers ranging
from 0 to 1 on an Excel file were used to determine the
groups, with a cutoff value of 0.5. The study office ad-
ministrative staff dealt with the enrolment of the partici-
pants and automatically assigned them to two groups
based on the Excel file. The allocation ratio for interven-
tion and control groups was 1:1 each year. In the trial,
the researchers who assessed outcomes did not know
the allocated group of each subject, but the subjects
knew which group they were allocated to. After
randomization, 28 subjects were included in the inter-
vention group and 30 in the control group. The sample
size was determined by sample size calculation. It was
assumed that approximately 30% of the women would
have an improved percentage recovery of blood flow
after the intervention, while approximately 0% (1% for
calculation purposes) of the women would have im-
proved in the control group. The result of the power cal-
culation was 87.1% with 28 subjects for each group.
The baseline and the eight-week follow-up examina-
tions were held at the Osaka Medical Center for Health
Science and Promotion on January 5 to 13 and March 1
to 10 in 2010, respectively, and on January 5 to 11 and
March 1 to 7 in 2011, respectively. In February 2010 and
2011, a physician monitored the participants’ health status,
daily symptoms of peripheral coldness, and gave lifestyle
guidance on the management of peripheral coldness for
both intervention and control groups, and monitored
side-effects for intervention group. Participants paid for
their own prescribed traditional herbal medicine, and all
participants received 10,000 yen after the trial.
Interventions
Women in the intervention group were administered
7.5 g of a traditional herbal medicine, TSUMURA & CO.
Tokishigyakukagoshuyushokyoto (TJ-38), per day (2.5 g,
three times a day) for eight weeks from January to
March, between the baseline and follow-up examina-
tions. The intake status of TJ-38 was recorded by the
participants and it was confirmed in the midpoint of
intervention by a physician. During the trial, two women
in the intervention group complained of a light stomach
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for the rest of the intervention period (two weeks). As
the symptoms disappeared after reducing the TJ-38 dose,
these two women were included in the analysis. No
other adverse effects were observed during the trial.
Subjects in the control group were asked to have a usual
life, and only received a lifestyle guidance on the man-
agement of peripheral coldness.
TJ-38 is a traditional herbal medicine in the form of a
granulated extract. A 7.5 g dose of TJ-38 contains 4.0 g
of a dried, water extracted mixture of nine crude drugs,
with magnesium stearate and lactose hydrate as addi-
tives. The proportions of the nine crude drugs are as fol-
lows: 5.0 g of jujube, 3.0 g of cinnamon bark, 3.0 g of
peony root, 3.0 g of Japanese angelica root, 3.0 g of ake-
bia stem, 2.0 g of glycyrrhiza, 2.0 g of evodia fruit, 2.0 g of
asiasarum root, and 1.0 g of ginger. Detailed information
regarding to these nine crude drugs are shown in Table 1.
The original plants and the quality of these crude drugs
are regulated by the Japanese Pharmacopoeia.Measurements
In the physical examination, we measured the subjects’
height in stockinged feet and weight in light clothing by
using an automated measuring instrument. Body mass
index was calculated as weight (kg)/height (m)2. Systolic
and diastolic arterial blood pressures were measured
twice by trained nurses using a mercury sphygmoman-
ometer on the right arm of the participants, in a sitting
position after five minutes of rest. The average of the
two blood pressure measurements was used for analysis.
Blood was drawn at fasting and the serum was sepa-
rated after centrifugation to measure serum total choles-
terol, LDL-cholesterol, HDL-cholesterol, triglycerides, hs
C-reactive protein. The whole blood was used to meas-
ure red blood cell counts, hemoglobin, and white blood
cell counts.Table 1 Information on nine crude drugs composed of Tokish
English Latin Japanese
Jujube Zizyphi Fructus Taisou
Cinnamon bark Cinnamomi Cortex Keihi
Peony root Paeoniae Radix Shakuyaku
Japanese Angelica root Angelicae Radix Touki
Akebia stem Akebiae Caulis Mokutsu
Glycyrrhiza Glycyrrhizae Radix Kanzou
Evodia fruit Euodiae Fructus Goshuyu
Asiasarum root Asiasari Radix Saishin
Ginger Zingiberis Rhizoma Shoukyou
All of the nine crude drugs are under quality control based on 16th edition of the JPeripheral blood flow and skin temperature
The cold bathing test was performed in a room in which
the temperature was maintained at 24 ± 1°C. After a
20 minute equilibrium period, participants placed both
hands into water at 4°C for 30 seconds. The peripheral
blood flow and skin temperature were measured before
submergence and then 1 and 10 minutes after the test.
Hands were wiped before those measurements. The per-
ipheral blood flow in the middle finger of the right hand
was measured using a laser Doppler device (Periflux
Systems System 4000, Perimed, USA). The signal processor
of this device establishes a linear relationship between
the flow meter output signal and the blood flow for all
flow rates. The performance of the signal processor was
evaluated through an experimental fluid model, which
optically resembles the blood flow through the microvas-
culature [17]. The skin temperature of the right hand
was measured by thermography (Infra Eye 2000B, Nihon
Koden, Japan).
The percentage recovery of peripheral blood flow or
skin temperature was calculated with the following
formula:
Percentage recovery of peripheral blood flow or skin temperature
¼ the value 10min after test−the value before test
the value before test−the value 1 after test
Women in both the intervention and control groups
also filled out a self-administered questionnaire for the
baseline and follow-up examinations, which included
items on the symptoms of coldness in the fingers, feet,
back, and whole body, lifestyle behaviors, and past illness.
The question about perceived coldness was: “In which part
of the body do you feel chilliness?”, and the selectable an-
swers (may be multiple) were: “fingers”, “feet”, “back”,
and/or “whole body”. In the questionnaire after the inter-
vention period, participants were asked an additional
question regarding perceived improvement of coldness
symptoms: “Did your symptoms of coldness improve?” forigyakukagoshuyushokyoto (TJ-38)
Chinese Dosage (g) Place of origin
da zao 5.0 China
gui pi 3.0 China
shao yao 3.0 Japan
dang gui 3.0 Japan
mu tong 3.0 Japan
gan cao 2.0 China
wu zhu yu 2.0 China
xi xin 2.0 China
sheng jiang 1.0 China
apanese pharmacopoeia.
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proved”, “somewhat improved”, “unchanged”, or “deterio-
rated”. For the analysis, we categorized the “substantially
improved” and “somewhat improved” as improved, and
“not changed” and “deteriorated” as not improved.
Lifestyle behaviors such as smoking, alcohol intake, ex-
ercise habits, and perceived mental stress were assessed.
As for smoking, current smokers were defined as per-
sons who smoked at least one cigarette per day for the
past three weeks. Alcohol intake was measured in “go”
(a traditional Japanese unit of volume corresponding to
23 g of ethanol) per week, which was afterwards con-
verted to grams of ethanol per day. One go is equivalent
to180 ml of sake, one bottle (500 ml) of beer, two single
shots (60 ml) of whiskey, or two glasses (240 ml) of
wine. Exercise habits were defined as exercising for 15
or more minutes a week for more than the past three
months. The question for perceived mental stress was:
“Do you experience stress in your job or your daily life?”,
for which the answers were “quite a lot”, “a lot”, “some-
what”, and “a little”. We defined “quite a lot” and “a lot”
as positive for perceived mental stress. Use of medica-
tion for hypertension, menopausal status, and otherFigure 1 Flow-chart of participants. Flow-chart of participant selection in
(TJ-38).aspects of health and symptoms during the past month
were also inquired by interviewers.
Statistical analysis
One woman in the intervention group could not partici-
pate in the follow-up examination because of a schedule
conflict (Figure 1). Therefore, the results included 27 in-
terventions and 30 controls for follow-up examination
and analysis.
Mean values and proportions of baseline characteris-
tics among the intervention and control groups were
calculated, and t-tests were conducted for means, and
chi-square tests for proportions of characteristics. The t-
tests were also conducted to evaluate the difference in
mean values of peripheral blood flow and skin
temperature between the intervention and control
groups, and chi-square tests to evaluate the difference in
the proportion of women whose percentage recovery of
blood flow after 10 min was >50% at the baseline and at
the eight-week follow-up examinations. The proportion
of perceived improvement of coldness was calculated
and compared between the intervention and control
groups by chi-square test. The proportion of perceptionthe randomized controlled trial using Tokishigyakukagoshuyushokyoto
Table 2 Mean values ± standard deviations and
proportions of baseline characteristics in the intervention
and control groups at the baseline examination
Baseline variables Intervention Control p value
Number 28 30
Age, year 49.4 ± 14.8 50.1 ± 13.2 0.86
Body mass index, kg/m2 20.6 ± 2.5 20.4 ± 3.0 0.72
Current smokers, % 7.1 3.3 0.52
Past smokers, % 14.3 16.7 0.81
Ethanol intake,
g/day
2.7 ± 6.4 3.1 ± 6.5 0.80
Habitual exercise, % 67.9 56.7 0.39
Perceived mental stress, % 39.3 43.3 0.76
Systolic blood pressure,
mm Hg
111.1 ± 17.4 106.9 ± 13.0 0.29
Diastolic blood pressure,
mm Hg




Total cholesterol, mg/dl 209.3 ± 27.3 213.0 ± 42.3 0.69
LDL-cholesterol, mg/dl 117.9 ± 25.2 124.2 ± 37.8 0.46
HDL-cholesterol, mg/dl 72.7 ± 12.5 70.8 ± 14.2 0.60
Triglycerides, mg/dl 78.9 ± 42.3 71.2 ± 28.8 0.42
Blood glucose, mg/dl 92.3 ± 4.8 91.7 ± 7.4 0.76
hs C-reactive protein,
mg/L
44.6 ± 47.7 56.2 ± 151.7 0.70
Red blood cell counts,
×104/mm3
404.7 ± 24.7 409.5 ± 32.1 0.53
Hemoglobin, g/dl 12.8 ± 1.2 12.8 ± 0.8 0.99
White blood cell
counts ×102/mm3
49.0 ± 13.5 43.7 ± 10.8 0.11
Menopause, % 42.9 46.7 0.78
Fatigue of the eye, % 82.1 66.7 0.18
Dizziness, % 50.0 36.7 0.31
Ear ringing, % 25.0 16.7 0.65
Headache, % 39.3 33.3 0.64
Shoulder stiffness, % 78.6 83.3 0.65
Hot flash, % 28.6 36.7 0.52
Cough, % 32.1 26.7 0.65
Diarrhea, % 25.0 13.3 0.26
Constipation, % 57.1 33.3 0.07
Pain in knee or
lower back, %
64.3 73.3 0.46
Palpitation, % 35.7 20.0 0.18
Short of breath, % 35.7 33.3 0.85
Swelling of lower extremities
and/or eyelids, %
64.3 43.3 0.11
Finger chilliness, % 64.3 53.3 0.41
Foot chilliness, % 67.9 70.0 0.86
Table 2 Mean values ± standard deviations and
proportions of baseline characteristics in the intervention
and control groups at the baseline examination
(Continued)
Back chilliness, % 46.4 36.7 0.46
Whole body chilliness, % 10.7 10.0 0.93
Peripheral blood flow, PUa) 81.9 ± 44.5 78.8 ± 52.8 0.82
Skin temperature, °C 29.9 ± 1.24 29.6 ± 1.43 0.61
a) PU: perfusion units = (number of moving blood cells in the measured
contents) × (average velocity of blood cells).
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control groups were calculated and compared by t-test.
At the baseline examination, two women in the inter-
vention group had higher blood flow values at 10 minutes
after the cold bathing test as compared to the value before
the test (percentage recovery blood flow >300%). These
two subjects were excluded for the sensitivity analysis.
Also, since smoking is one of the strong factors for vaso-
constriction, we conducted another sensitivity analysis by
excluding two current smokers in the intervention group,
and one smoker in the control group.
The 9.2 version of SAS was used for all statistical ana-
lyses. All statistical tests were two-tailed, and p < 0.05
was regarded as statistically significant.
Results
Table 2 shows the mean values and proportions of the
baseline characteristics of the participants. There were
no differences between the intervention and control
groups at the baseline in terms of age-adjusted mean
values of body mass index, systolic and diastolic blood
pressures, selected blood chemistry and hematology,
peripheral blood flow before bathing, skin temperature,
and age-adjusted proportions of peripheral body chilli-
ness, peripheral coldness related symptoms, current and
past smoking habits, exercise habits, perceived mental
stress, use of antihypertensive medications and meno-
pausal status.
Table 3 shows the peripheral blood flow and Table 4
shows the skin temperature of the participants at the
baseline examination in January, and at the eight-week
follow-up examination in March 2010 and 2011, for all
participants (n = 58) and for participants without an ab-
normally high percentage recovery of blood flow
(n = 56) at the baseline. Mean values of the percentage
recovery of peripheral blood flow for all the participants
in the intervention and control groups at the baseline
examination were 13.3% and −27.8%, respectively (p for
difference = 0.07), and those of the skin temperature
were −9.6% and −13.5% (p = 0.04), respectively. Mean
value of the percentage recovery of peripheral blood
flow after the TJ-38 treatment in the intervention group
was 17.2%, whereas it remained at −28.2% in the control
Table 3 Mean values ± standard deviations of blood flow in the intervention and control groups at the baseline and at
the eight-week follow-up examinations
Baseline Follow-up
Intervention Control p value Intervention Control p value
Total participants
Number 28 30 27 30
Blood flow before bathing, PU 81.9 ± 44.5 78.8 ± 52.8 0.82 102.1 ± 60.3 101.5 ± 64.9 0.97
Blood flow 1 min after bathing, PU 50.7 ± 23.0 47.6 ± 23.2 0.61 59.1 ± 27.2 61.1 ± 37.3 0.82
Blood flow 10 min after bathing, PU 91.8 ± 85.0 51.0 ± 46.3 0.03 107.8 ± 71.4 80.1 ± 75.2 0.16
Percentage recovery of blood flow after 10 min, % 13.3 −27.8 0.07 17.2 −28.2 0.007
Participants without percentage recovery of peripheral blood flow >300% at the baseline (sensitivity analysis)
Number 26 30 25 30
Blood flow before bathing, PU 84.0 ± 45.1 78.8 ± 52.8 0.70 103.9 ± 62.3 101.5 ± 64.9 0.89
Blood flow 1 min after bathing, PU 51.0 ± 23.1 47.6 ± 23.2 0.59 59.6 ± 27.9 61.1 ± 37.3 0.87
Blood flow 10 min after bathing, PU 80.7 ± 75.1 51.0 ± 46.3 0.08 109.2 ± 73.6 80.1 ± 75.2 0.16
Percentage recovery of blood flow after 10 min, % −13.1 −27.8 0.29 17.7 −28.2 0.008
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percentage recovery of skin temperature after the treat-
ment did not differ between the intervention and control
groups. When the two women with percentage recovery
of peripheral blood flow >300% at the baseline examin-
ation were excluded, the results did not change materially.
Mean values of percentage recovery of peripheral blood
flow were −13.1% in the intervention group and −27.8% in
the control group (p for difference =0.29) at the baseline
examination and 17.7% and −28.2%, respectively (p for dif-
ference = 0.008) at the follow-up examination.
When current smokers (2 in the intervention and 1 in
the control groups) were excluded, there were no major
difference in the results; mean values of percentageTable 4 Mean values ± standard deviations of skin temperatu





Skin temperature before bathing, °C 29.9 ± 1.24
Skin temperature 1 min after bathing, °C 24.0 ± 0.83
Skin temperature 10 min after bathing, °C 27.0 ± 2.79
Percentage recovery of skin temperature after 10 min, % −9.6
Participants without percentage recovery of peripheral blood flow >300% at
Number 26
Skin temperature before bathing, °C 29.9 ± 1.26
Skin temperature 1 min after bathing, °C 24.0 ± 0.77
Skin temperature 10 min after bathing, °C 26.8 ± 2.74
Percentage recovery of skin temperature after 10 min, % −10.7recovery of blood flow were 16.1% in the intervention
group and −25.8% in the control group (p for difference =
0.08) at the baseline examination, and 23.2% and −26.7%,
respectively (p for difference = 0.004) at the follow-up
examination.
Table 5 shows the number and proportion of women
in the intervention and control groups whose percentage
recovery of blood flow after 10 min was >50% at the
baseline and follow-up examinations. The proportion of
women with >50% increase in the percentage recovery
of peripheral blood flow increased in the intervention
group (from 21% to 32%), whereas it decreased in the
control group (10% to 0%) (p = 0.0007 at the follow-up
examination). The sensitivity analysis excluded the twore in the intervention and control groups at the baseline
Follow-up
Control p value Intervention Control p value
30 27 30
29.6 ± 1.43 0.43 30.1 ± 1.35 29.9 ± 1.71 0.56
23.7 ± 0.80 0.32 24.0 ± 0.99 23.9 ± 1.09 0.89
25.6 ± 2.14 0.03 27.6 ± 2.72 26.5 ± 3.01 0.17
−13.5 0.04 −8.5 −11.4 0.14
the baseline (sensitivity analysis)
30 25 30
29.6 ± 1.43 0.34 30.2 ± 1.40 29.9 ± 1.77 0.54
23.7 ± 0.80 0.18 24.0 ± 1.03 23.9 ± 1.09 0.89
25.6 ± 2.14 0.08 27.6 ± 2.83 26.5 ± 3.01 0.20
−13.5 0.11 −8.7 −11.3 0.19
Table 5 Number and proportion of women whose percentage recovery of blood flow after 10 min was >50%, for the
intervention and control groups at the baseline and at the eight-week follow-up examinations
Baseline Follow-up
Intervention Control p value Intervention Control p value
Total participants
Number 28 30 27 30
Percentage recovery of blood flow after 10 min >50% 6 (21%) 3 (10%) 0.23 9 (32%) 0 (0%) 0.0007
Participants without percentage recovery of peripheral blood flow >300% at baseline (sensitivity analysis)
Number 26 30 25 30
Percentage recovery of blood flow after 10 min >50% 4 (15%) 3 (10%) 0.54 9 (35%) 0 (0%) 0.0004
Proportions of the percentage recovery of blood flow after 10 min that were >50% are shown in parentheses.
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flow >300% at the baseline examination showed similar
results: 15% to 35% in the intervention group, and 10%
to 0% in the control group (p for difference =0.0004 at
the follow-up examination). When current smokers were
excluded, there were no major difference in the results;
the proportion of women with >50% increase in the per-
centage recovery of peripheral blood flow was 23% in
the intervention group and 10% in the control group (p
for difference = 0.21) at the baseline examination, and
35% and 0%, respectively (p for difference = 0.0005) at
the follow-up examination.
The perception of improved peripheral coldness was
reported by 81% of the women in the intervention group
and 13% of the women in the control group (p < 0.001).
Women who felt an improvement in peripheral coldness
tended to have the greater mean value of the percentage
recovery of blood flow than participants who felt other-
wise: 9% in the intervention group and −20% in the con-
trol group (p for difference = 0.08 at the follow-up
examination). The results did not change materially
when we excluded the two women with percentage re-
covery of peripheral blood flow >300% at the baseline
examination: 9% in the intervention group and −20% in
the control group (p for difference = 0.10). When current
smokers were excluded, there were no major difference
in the results; 15% in the intervention group and −18%
in the control group (p for difference = 0.06).
Discussion
In the present parallel-group randomized controlled trial,
women in the intervention group showed significant re-
covery of peripheral blood flow in the finger after the cold
bathing test, as well as subjective improvement of periph-
eral coldness, whereas women in the control group experi-
enced reduced recovery of peripheral blood flow and less
subjective improvement. The exclusion of the two women
(non-smokers) with an abnormally high percentage recov-
ery of peripheral blood flow in the intervention group at
the baseline examination did not alter the result, and sup-
ported the evidence of improvements in the recovery ofperipheral blood flow and in peripheral coldness. The per-
centage recoveries of peripheral blood flow at the baseline
examination for these two women were 307% and 406%,
and at follow-up examination 29% and −7.6%, respectively.
Both women reported subjective improvement in periph-
eral coldness. No other participants from either the inter-
vention or control group showed a percentage recovery of
peripheral blood flow >300% (at most 227%) at the follow-
up examination. Therefore, the very high percentage re-
coveries of peripheral blood flow at the baseline examin-
ation were likely to be outliers, and were probably due to
measurement error.
A randomized controlled trial of 72 children (39 boys
and 33 girls aged 4 to 18 years) experiencing peripheral
coldness showed that subjective improvement of symp-
toms was observed in 94% of the TJ-38 treatment group,
whereas it was 54% for the vitamin E treatment group
and 20% for the control group [18]. Another non-
randomized trial involving 70 male patients who were
chainsaw users with peripheral blood flow disturbance
showed that the percentage recovery of skin temperature
after the cold bathing test was larger in the group with
TJ-38 treatment and physiotherapy, compared to that of
the group treated with physiotherapy alone [19].
Our study is the first to analyze the effects of TJ-38 on
peripheral coldness using an objective index (peripheral
blood flow) and a subjective criterion (improvement of
peripheral coldness) in a randomized controlled trial.
Therefore, our study provides robust evidence of the ef-
fectiveness of TJ-38 in improving peripheral coldness.
The mechanism of TJ-38 on peripheral coldness is
not well established. One of the pharmacological effects
of TJ-38 may be the activation of autonomic nerve func-
tion. A study of eight healthy volunteers showed that
plasma noradrenalin concentrations increased, and that
the Low Frequency/High Frequency ratio in heart rate
variability, an index of parasympathetic nerve activity,
decreased two hours after the administration of TJ-38
[20]. Another study reported that evodiamine (in
Goshuyu, an ingredient of TJ-38), a chemical extracted
from Evodia fruit in the Tetradium family of plants, is
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nel, subfamily V, member 1 (TRPV1), which promotes ni-
tric oxide production in endothelial cells, and thereby
relaxes the smooth muscles of vessels [13]. An extract
from Paeoniae Radix (Syakuyaku, another ingredient of
TJ-38) has vasodilatory and anticoagulant effects [14]. Ad-
enosine, ligustilide, and butylidenephthalide from Angelica
acutiloba, another ingredient of TJ-38, were reported to
have an inhibitory activity against platelet aggregation
[21,22]. These vasodilator and anticoagulation effects may
contribute to the improvement in peripheral blood flow
and peripheral coldness.
The limitations of this study are as follows: Firstly,
subjects in the control group did not take placebo in this
trial because it is very difficult and in many cases impos-
sible to produce placebo for its unique smell and taste.
However, measurement of percent recovery of peripheral
blood flow was an objective measure, was blind for
intervention or control. No placebo control unlikely lead
to the biased results. Secondly, the measurement errors
for the peripheral blood flow and skin temperature were
inevitable. In a previous study [23], the coefficient of vari-
ation of blood flow (Periflux Systems) of five subjects on
five different days within 2-3 weeks was 20-21%. In the
present trial, however, two women in the intervention
group showed an abnormally high percentage recovery of
peripheral blood flow at the baseline examination. That
potential measurement error might reduce the compar-
ability of the mean percentage recovery of peripheral
blood flow at the baseline examination between the two
groups, although the difference did not reach statistical
significance. Thirdly, we did not evaluate the vasodilatory
and anticoagulation effects of TJ-38 directly because of
the technical difficulty. That evaluation, however, would
have made the mechanism clearer.
Conclusions
We demonstrated that eight-week administration of
TJ-38, a traditional herbal medicine, improved peripheral
blood flow and perception of peripheral coldness in
women experiencing peripheral coldness in a random-
ized controlled trial.Competing interests
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